gout + antiinflammatories Flashcards

(73 cards)

1
Q

what do you screen for when someone has gout

A

HTN, DM, hyperlipidemia, CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

M/C cause of hyperuricemia

A

decreased excretion of urate by kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 main categories of gout MANAGEMENT

A

xanthine oxidase inhibitors

uricosuric agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACUTE gout anti-inflammatories

A
  1. NSAIDS - naproxen > ibuprofen
  2. prednisone (if CKD, cirrhosis, HF)
  3. colchicine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what two acute anti-inflammatory combos should you avoid & WHY

A

steroids, NSAIDS

can –> GI toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

risk factor reduction for gout

A

weight loss, decrease CV risk factors, manage BP, exercise, hydration, smoking
decrease intake of SSB (fructose!!), organ meats, red meats, ETOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what pts should be on anti-hyperuricemic therapy

A
  • frequent/disabling gout attacks (>2/yr)
  • men <25 OR premenopausal women
  • gout w CKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ADRs of colchicine

A
  • diarrhea
  • myopathy, rhabdo
  • bone marrow suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

do not combine colchicine with…

A
  • 3A4 or pgp inhibitors (clarithromycin, cyclosporine)

- statins, fibrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

goals of serum [UA] in gout

A

<6 or <5 if tophi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when do you initiate anti-hyperuricemic therapy

A

when acute gout attack has resolved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

xanthine oxidase inhibitors

A

allopurinol

febuxostat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

xanthine oxidase of choice

A

allopurinol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what to screen for with allopurinol and why

A

HLA-B5801 –> at higher risk of DRESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what do you adjust for with allopurinol tx

A

GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADR of allopurinol

A

paradoxical gout flare
bone marrow suppression
drug fever
rash, DRESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

BBW for febuxostat

A

cardiac safety concerns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

uricosuric agent

A

probenecid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

probenecid MOA

A

basically, urate diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

before starting someone on probenecid, pts must have

A

good renal function - GFR >50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

pegloticase MOA

A

turns UA into a water soluble metabolite that can be excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

when would you use pegloticase

A

severe gout, debulking for tophi, last resort!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

biosimilars must have the same __ compared to OG drug

A
  • MOA
  • dose
  • strength
  • route
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how soon should you initiate non-biologic DMARD therapy

A

within 3 months of the diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
when should you use a biologic DMARD
when pt doesn't respond to non-biologic, have moderate disease, or intolerant to DMARD
26
triple therapy anti-inflammatory regimen
MTX + hydroxychloroquine + sulfasalazine
27
biologic therapy anti-inflammatory regimen
MTX + TNF-inhibitor
28
what to use to decrease inflammatory symptoms
low dose steroids, NSAIDS
29
immunizations for people with inflammatory conditions
``` influenza pneumonia (both) VZV HBV HPV ```
30
when should immunizations be given
1 month prior to initiating DMARD
31
non-biologic DMARDS
- MTX - leflunomide - sulfasalazine - hydroxychloroquine - JAK inhibitors (-citinibs)
32
MTX MOA
folate antimetabolite that inhibits DNA synthesis
33
indications for MTX
- tumors/CA - RA - psoriasis/psoriatic arthritis
34
monitoring for MTX
- CXR, PFT - HBV/HCV test - CBC, CMP
35
ADRs for MTX
- stomatitis - GI intolerance - pulmonary toxicity - hepatotoxicity (LFT abnormalities) - nephrotoxicity - bone marrow suppression
36
drug interactions of MTX
- other anti-folate drugs (TMP-SMX) - other drugs that affect kidneys (NSAID, transplant drugs, diuretics) - PPIs increase MTX conc.
37
what should you supplement MTX with & why
folate to decrease ADRs
38
when should you take pts off MTX & why
sick pts in hospital --> risk of aplastic crisis
39
reversal agent for MTX
levocovorin
40
leflunomide indications
RA/psoriatic arthritis in pt who had MTX toxicity
41
leflunomide ADRs
- diarrhea - reversible alopecia - LFT abnormalities
42
hydroxychloroquine indications
- RA - SLE - anti-malaria
43
do not use hydroxychloroquine if...
hx of retinal/visual field abnormalities | pts with renal insufficiency
44
hydroxychloroquine ADRs
- ophthalmic issues - QTC issues - hemolysis in G6PD pts
45
sulfasalazine indications
- RA | - IBD
46
common sulfasalazine ADRs
- GI intolerance | * sulfa rash!
47
JAK inhibitors
tofacitinib baricitinib upadacitinib
48
JAK inhibitor indications
mod-severe RA
49
what are pts on JAK inhibitors at risk of
thromboembolic events
50
1ST line TNF-inhibitors
- infliximab - adalimumab - etanercept
51
2nd line TNF inhibitors
certolizumab | golimumab
52
TNF inhibitors indications
- mod-severe RA - psoriatic arthritis - severe plaque psoriasis - IBD - ankylosing spondylitis - sJIA
53
what are TNF-inhibitors typically used with
MTX
54
screening for pts on TNF inhibitors
``` CA TB (IGRA, TST) CXR HIV HBV HCV ```
55
acute ADRs of TNF-inhibitors
injection site rxn infusion rxn URTI GI intolerance
56
serious ADRs of TNF inhibitors
- lupus - MS - bone marrow suppression - malignancies - increased risk for serious infections
57
what type of infections are pts on TNF inhibitors at risk of
TB reactivation invasive fungal infection bacterial infection
58
all other drugs biologic DMARDS (besides TNF-inhibitors) are generally only used for...
RA pts who dont respond to TNF inhibitor
59
T cell costimulation/activation inhibitor
abatacept
60
cd20 mab
rituximab
61
IL-1 antagonist
anakinra
62
IL-6 antagonist
toclizumab | sarilumab
63
acute psoriatic arthritis tx
NSAIDS, intraarticular or low-dose systemic steroids
64
long-term psoriatic arthritis tx
mild: NSAIDS | mod-severe: MTX, leflunomide --> add TNF-inhibitors if no improvement in 12-16 weeks --> then other agents
65
apremilast
PDE4 inhibitor | psoriatic arthritis
66
secukinumab
il-17 antagonist
67
ixekizumab
il-17 antagonist
68
ustekinumab
il-12/23 antagonist
69
what other non-biologic & biologic DMARD can you use for psoriatic arthritis
abatacept | tofacitinib
70
systemic juvenile idiopathic arthritis characteristics
daily high fever evanescent MP rash inflammatory polyarthritis
71
tx for mild-moderate sJIA
- NSAID - systemic glucocorticoid - or both
72
pts with sJIA with FEW systemic features (fevers)
- DMARD (MTX + TNFinhibitor)
73
pts with sJIA with prominent systemic features (fevers)
- high does corticosteroids - tocilizumab or anakinra - canakinumab